Effects of group housing on ECG assessment in conscious cynomolgus monkeys.
暂无分享,去创建一个
Jin Ren | Karen Oldman | Guozhen Xing | Jing Lu | Miaomiao Hu | Shaodong Wang | Li Zhao | Weijun Zheng | Jason Schofield | Debbie Adkins | Hong Yu | Stefan Platz | Matthew Skinner
[1] Jennifer Sims,et al. The design of chronic toxicology studies of monoclonal antibodies: implications for the reduction in use of non-human primates. , 2012, Regulatory toxicology and pharmacology : RTP.
[2] J. Wyatt,et al. Pair housing of macaques in research facilities: a science-based review of benefits and risks. , 2011, Journal of the American Association for Laboratory Animal Science : JAALAS.
[3] T. Baird,et al. Preclinical QT safety assessment: cross-species comparisons and human translation from an industry consortium. , 2014, Journal of pharmacological and toxicological methods.
[4] H. Vargas,et al. Assessment of two external telemetry systems (PhysioJacket and JET) in beagle dogs with telemetry implants. , 2009, Journal of pharmacological and toxicological methods.
[6] Thomas Trautmann,et al. Optimizing the experimental environment for dog telemetry studies. , 2006, Journal of pharmacological and toxicological methods.
[7] Michael D B Swedberg,et al. A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions. , 2013, Journal of pharmacological and toxicological methods.
[8] D. Gauvin,et al. Electrocardiogram, hemodynamics, and core body temperatures of the normal freely moving cynomolgus monkey by remote radiotelemetry. , 2006, Journal of pharmacological and toxicological methods.
[9] Jean-Pierre Valentin,et al. Non-invasive telemetric electrocardiogram assessment in conscious beagle dogs. , 2009, Journal of pharmacological and toxicological methods.
[10] D J Gallacher,et al. Best practice in the conduct of key nonclinical cardiovascular assessments in drug development: current recommendations from the Safety Pharmacology Society. , 2012, Journal of pharmacological and toxicological methods.
[11] Hugo M Vargas,et al. Nonclinical strategy considerations for safety pharmacology: evaluation of biopharmaceuticals , 2013, Expert opinion on drug safety.
[12] Hugo M Vargas,et al. Safety pharmacology investigations in toxicology studies: an industry survey. , 2013, Journal of pharmacological and toxicological methods.
[13] W Suter,et al. How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines? , 2011, British journal of pharmacology.
[14] C. Shively,et al. Effects of chronic social separation on cardiovascular disease risk factors in female cynomolgus monkeys. , 1998, Atherosclerosis.
[15] M. Kenward,et al. Small sample inference for fixed effects from restricted maximum likelihood. , 1997, Biometrics.
[16] A. Bass,et al. Measuring the risk of torsades de pointes: electrocardiographic evaluation of PNU-142093 in conscious cynomolgus non-human primates using restraint and non-restraint procedures. , 2009, Journal of pharmacological and toxicological methods.
[17] W. Gu,et al. Detection of QTc interval prolongation using jacket telemetry in conscious non‐human primates: comparison with implanted telemetry , 2014, British journal of pharmacology.
[18] Jean-Pierre Valentin,et al. Functional assessments in repeat-dose toxicity studies: the art of the possible , 2013 .